SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-234607
Filing Date
2012-05-15
Accepted
2012-05-15 16:16:21
Documents
13
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d339542d10q.htm 10-Q 469755
2 REVENUE PARTICIPATION AGREEMENT d339542dex106.htm EX-10.6 684850
3 FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT d339542dex107.htm EX-10.7 59049
4 FORM OF WARRANT d339542dex108.htm EX-10.8 67997
5 CERTIFICATION OF CEO PURSUANT TO SECTION 302 d339542dex311.htm EX-31.1 9619
6 CERTIFICATION OF CFO PURSUANT TO SECTION 302 d339542dex312.htm EX-31.2 9877
7 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 d339542dex321.htm EX-32.1 4891
13 GRAPHIC g339542forma_1-1.jpg GRAPHIC 1471
  Complete submission text file 0001193125-12-234607.txt   2462608

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT snss-20120331.xml EX-101.INS 185654
9 XBRL TAXONOMY EXTENSION SCHEMA snss-20120331.xsd EX-101.SCH 9227
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20120331_cal.xml EX-101.CAL 28692
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20120331_lab.xml EX-101.LAB 93731
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20120331_pre.xml EX-101.PRE 58721
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 12844893
SIC: 2834 Pharmaceutical Preparations